BioMed Research International / 2015 / Article / Tab 1 / Review Article
Lipid Mediators Are Critical in Resolving Inflammation: A Review of the Emerging Roles of Eicosanoids in Diabetes Mellitus Table 1 Eicosanoid compounds as targets for drug development to control diabetes progression.
Drug Target Condition Consideration Reference Celecoxibe COX-2 inhibitor Diabetes nephropathy Female patients received higher dose of PGs vasodilator to maintain blood vessel function than male patients.
[74 ]
Aspirin Nonselective COX inhibitor Diabetes retinopathy Delay in development of retinal microaneurysms in DR.
[75 ]
Celecoxibe COX-2 inhibitor Diabetes retinopathy Reduction of vascular leakage.
[76 ]
Latanoprost PGF2 agonist Diabetes retinopathy Reduces the diameter of dilated retinal arterioles.
[77 ]
Ketorolac tromethamine Nonselective COX inhibitor Diabetes retinopathy Patients with suspected or visible fibrovascular proliferation demonstrated a reduction in IL-8 and platelet-derived growth factor levels in vitreous humor.
[78 ]